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【研究の背景と目的】 
 当教室では 1984 年以来、独自に開発したラット用 fluid-percussion injury 装置を用い、受傷後早
期（２時間）に脳挫傷側大脳皮質で糖代謝が亢進することを見いだし（中村ら 1986,1987: 昭和
59 年 文部省科学研究費 B-59480301）、この現象が脳波およびDCポテンシャルの解析結果から 
spreading depressionに由来するものであることを明らかにした（角南ら 1990: 昭和 59 年 文部
省科学研究費 B-59480301）。その後海外においても、ヒトの頭部外傷後急性期に脳糖代謝が亢進
し（Becker 1994）、spreading depression も起こりうることが報告され（Mayevsky 1994）、当教室
の実験頭部外傷モデルがヒト頭部外傷の病態をよく反映していることが明らかとなった。最近は、
低体温によりspreading depressionの発生頻度が減少し（宮田ら 1992）、ストレス蛋白（HSP72）の
発現が減少すること(中村ら 1995)を報告し、また一方で、免疫組織化学的手法を用いて受傷後の
血液脳関門の破綻（丹野ら 1992、福田ら 1993）、HSP72 の発現（丹野ら 1992、中村ら 1995）、
astrocyte （興村ら 1994）と microglia の反応を経時的に観察してきた。平成 7・8年度科学研究
費補助金 基盤研究C(2) 07671499では（研究者：山浦 晶、山上岩男、題目：実験的脳挫創に
およぼす人為的脳温変化の影響について）ラットを用いた 34 度C、2 時間の低体温ではmicroglia
には明らかな活性化の抑制は認められなかったがastrocyteの反応を減弱させる傾向を認めた。 
 Microglia は脳内での phagocytosis や炎症反応の中核をなすのみならず、近年頭部外傷がそ
のリスク因子の一つとして報告されている（Mortimer et al.,1991; Mayeux et al.,1995）アルツ
ハイマー病の老人斑形成とも関連の深いことが判明している。平成 9・10・11 年度科学研究費補
助金 基盤研究B(2) 09470289（研究者：山浦 晶、山上岩男、岩立康男、平井伸治、村井尚之 題
目：Microgliaとspreading depressionの神経損傷への影響）では、頭部外傷後の神経行動学的評価の
開発とmicroglia の反応を中心に研究を進めた。Microglia の活性化を抑制するFK-506 を外傷直後
に一回投与を行った場合、一週後ではOX-42 陽性microgliaは減少が見られないが神経細胞数の減
少が有意に抑制され神経保護効果が認められた。一方、連日一週間投与した場合ではOX-42 陽性
microgliaの減少が見らたが神経細胞数の減少は抑制されず神経保護効果が見られなかった。この
ことは、外傷後早期のmicrogliaは損傷した神経細胞を細胞死に導く一方、一週以内にはneurotrophic
な効果が優位となっている可能性が示唆している。このように神経細胞死と神経栄養因子産生の
双方の顔を持つmicrogliaの反応を充分に解明し、適切に修飾することができれば頭部外傷後の神
経細胞死、運動機能障害、学習・記名能力障害に対する有効な治療手段となりうると大いにに期
待され、臨床的にも極めて重要な課題となる。 
 本研究では、具体的には次の項目を目的とした。 
1. 頭部外傷後に誘導される活性化 microglia に対し、神経細胞死との関連、神経保護的性質等
をより明らかにするために、免疫組織化学的検討を中心とした解析を行う。 
2. 活性化microgliaが急性期および慢性期にどのような物質を産生しているのかについて検討す
る。 
3. 培養 microglia の移植について基礎的検討を行う。 
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【研究の経過】 
１． 新しい頭部外傷作成装置の導入と頭部外傷モデルの改良 
 本研究の当初 1984 年に当教室で開発し、以来使用してきたラット用 fluid-percussion injury
外傷作成装置の老朽化に伴い一部改良を加えた。また、外傷の程度のばらつきを少なくし実験の
効率化を図るために、外傷時の体温や生理学的反応を詳細かつ連続的にモニターし条件をより整
えることが必要で、高速 8ch 入力用インタフェイス（平成 12 年度請求分）を用いコンピューター
上でデータの監視および記録を行った。しかしながら装置の改修により視床等の脳深部には安定
した障害を作成できるようになった一方、大脳皮質の障害は軽くなる傾向になり、大脳皮質の研
究には難渋する結果となった。そこで大脳皮質に安定してより強い障害が作成可能な controlled 
cortical impact injury 装置を本研究以外の経費から購入し、当教室での controlled cortical 
impact injury モデルの確立にむけて実験を開始したが、機械の購入に手間取りモデルを確立する
には至らず、今回はより単純な stab wound を用いることとした。 
 
２． Immunotoxin を用いた microglia ablation study 
Microglia の神経細胞死に働く面と神経保護的に働く面とそのどちらが神経外傷の急性期には有
意となっているのか、monocyte/microglia 特異的 immunotoxin (1T/anti-Mac1-SAPORIN)を用い
microglia を ablation してその効果をみた。結果は研究成果の項を参照。  
 
３．Microglia の移植に関する基礎的実験 
今回は microglia の培養を開始するにとどまり、ラベリングと移植については今後の課題となっ
た。 
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【研究成果】 
The effects of microglia ablation following traumatic brain 
injury in mice 
 
Abstract 
As a whole, whether activated microglia are acting as protectors or attackers to the 
neurons in response to the certain pathological condition such as trauma? In this study 
we used microglia-specific immunotoxin, Mac-1-SAPORIN, at the time of injury to 
temporally eliminate microglia to see the effects following penetrating traumatic brain 
injury in mice. 
At 24 hours after injury, very few arborized microglia were observed around the 
injury site in microglia ablation group, while arborized microglia were widely 
distributed around the injury site or throughout the ipsilateral hippocampus and 
round-shaped microglia/macrophage were sparsely distributed along the needle track in 
microglia non-ablation group. At 7 days after injury, many arborized microglia were 
observed around the injury site or throughout the ipsilateral hippocampus even in 
immunotoxin treated (microglia ablation) group. Gliosis around the injury site was more 
evident in microglia non-ablation group at 72 hours and 7 days following injury. At 72 
hours after injury, the neuronal cell loss became evident in the non-ablation group 
compared to that in ablation group. However, at 7 days after injury, no statistically 
significant difference was observed. 
The microglia ablation with immunotoxin ameliorated the neuronal cell loss in the 
dentate gyrus following penetrating traumatic brain injury in the mouse hippocampus.  
The microglia ablation also inhibited the hypertrophic change and proliferation of 
astrocytes following traumatic brain injury. We concluded that activated microglia in 
the acute stage of penetrating brain injury are considered to mainly act on the neurons 
suffering from injury as attackers through their phagocytic function and/or modification 
of astrocyte-neuron interaction.   
 
Key words: traumatic brain injury, microglia, astrocyte, neuron, 
immunotoxin 
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IntroductionMicroglia, composed of about 10% of the whole cell population in the 
central nervous system (CNS), are very sensitively activated under pathological 
conditions such as ischemia, inflammation, Alzheimer’s disease, brain tumors and 
trauma1). Traditionally, microglia have been viewed as mere scavengers activated 
secondary to the neuronal damage2). However, recent studies indicate various functional 
roles of activated microglia involved in cytotoxicity, tissue repair and neural 
degeneration through antigen presentation3), cytokine secretion4), nitric oxide release5) 
etc under pathological conditions described as above.  
Such variety of functional roles of activated microglia causes a fundamental question: 
as a whole, activated microglia are protectors or attackers to the neurons in the sequel of 
certain pathological condition?  In this experimental study we speculate the answer in 
penetrative brain injury by the microglial ablation method using microglia-specific 
immunotoxin6). 
 
Materials and methodsAnimals and surgical proceduresExperiments 
were performed on 36 adult male C57/BL6 mice (Nippon SLC, Hamamatsu, Japan) 
weighing about 20-25g housed in a 12 hour-light-dark controlled cycle with free access to 
food and water. All animal procedures were in strict accordance with the NIH Guide for 
the Care and Use of Laboratory Animals and performed under the approval of the local 
Animal Care Committee.  
Animals were divided into two groups (n=18 in each), A and B.  In group A, 
Mac-1-SAPORIN Targeted immunotoxin-mouse microglia-specific immunotoxin 
(MAC-1-SAP: Chemikon International INC., Temecula, CA) dissolved in PBS was 
intracerebrally administrated while only PBS was administrated as a control in group B. 
All animals were anesthetized with 60mg/kg sodium pentobarbital intraperitoneally and 
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placed in a stereotaxic apparatus (Narishige, Japan) and the scalp was incised at midline 
and retracted laterally to make a burr hole at an appropriate location (2.0mm posterior 
to bregma, 1.2mm left to midline) determined according to the mouse brain map.  A 
23-gauge needle of 10μl microsyringe (KLOEHN LTD) was inserted to the point of 
2.0mm ventral from dura and 100ng of MAC-1-SAP in 1μl of PBS (in group A) or the 
same volume of PBS (in group B) were slowly injected manually spending 3 minutes. 
The needle was kept in place for 5 minutes and then withdrawn spending 1 minute. 
At 24 and 72 hours, and 7 days after injury, animals (n=6 respectively in each group) 
were deeply re-anesthetized and perfused intracardially with 30ml of 4% 
paraformaldehyde in 0.1MPB, pH7.4. Brains were removed and post-fixed in the same 
fixatives for 24 hours. Coronal brain section around the needle penetration was then 
excised and processed for paraffin embedment. Finally 5μm-thick coronal sections were 
serially prepared on slideglasses for histological and immunohistochemical examination. 
 
Immunohistochemistry (Table 1) 
After identification of the needle track, the following monoclonal or polyclonal 
antibodies were used for immunohistochemical study: rat anti-mouse F4/80, a plasma 
membrane antigen of unknown function specific for microglia/macrophages (Serotec 
Ltd, Oxford, England); mouse anti-NeuN, neuron-specific nuclear protein (Chemikon 
International INC., Temecula, CA); rabbit anti-human GFAP, cytoskeletal protein 
specific for astrocytes (Zymed Laboratories, INC., San Francisco, CA). Each 
immunohistocemistry was performed on the adjacent deparaffinized sections from the 
needle track as a center for observation in three series at 20μm intervals.  For 
antigen-retrieval, sections were firstly incubated in 5μg/ml proteinaseK/0.05MPBS at 
37 for 15 min in F4/80 immunohistochemistry while other sections were incubated 
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in10μΜ citrate buffer at 110℃ for 10 min in GFAP immunohistochemistry.  Sections 
were then soaked for 10 min in 1% hydrogen peroxide (H2O2) to inactivate any 
endogenous peroxidase and pre-incubated at room temperature for 1 hour in 0.05MPBS 
containing 0.2% Triton X, 0.1% bovine serum albumin, and 10% normal rabbit (for 
F4/80) or goat (for GFAP) serum, or 4% Moue Ig Blocking Reagent (for NeuN) from 
M.O.M.TM Immunodetection Kit (Vector Laboratories, Inc.). Then the sections were 
incubated with each primary antibody (F4/80 1: 50, NeuN 1: 100, GFAP 1: 50) overnight 
at 4℃. Non-immune rabbit (for F4/80) or goat (for GFAP) serum or 0.05MPBS (for 
GFAP) were used for the negative control. After rinsing in 0.05MPB, each secondary 
antibody (biotinylated rabbit anti-rat IgG (Vector Laboratories, Inc.) for F4/80 1: 200, 
biotinylated anti-mouse IgG (Vector Laboratories, Inc.) for NeuN 1: 250, 
HRP-conjugated goat anti-rabbit IgG (Life Technologies) for GFAP 1: 100) was applied 
to the sections and reacted for 1 hour at room temperature, followed by treatment with 
ABC reagent (1: 500) from Vectastain ABC kit (Vector Laboratories, Inc.) in F4/80 and 
NeuN immunohistochemistry. The reaction products of the ABC immunostaining(F4/80 
and NeuN) or the indirect immunostaining(GFAP) were visualized by Nickel-enhanced 
DAB for F4/80, DAB for NeuN, and 3-amino-9-ethylcarbazole (AEC) for GFAP, 
respectively. All the stained sections were examined and photographed under light 
microscope (Olympus BX60). 
 
Quantification of neuronal loss and statistical analysisThe numbers of the 
NeuN-positive neurons in the dentate gyrus around the injury were determined using a 
light microscope at a magnification of 1: 200 on three sections in every animal. An area 
of 400?300μm  of each field in an ocular grid was examined (Figure 3). This analysis 
was performed twice by two of the authors without knowing the group and the time 
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point after inury as an estimate of the reliability of the cell counting method.  Following 
the calculation of the mean value on the three sections in each animal, statistical 
comparisons were made in each time point after injury between group A&B using 
Student’s-t test (p<0.05). Schematic summary of experimental protocol is shown in 
figure 1. 
Results 
F4/80: Activated microglia (Figure 2) 
At 24 hours after injury, no (n=5) or very few (n=1) arborized microglia were 
observed around the injury in group A while arborized microglia were widely 
distributed around the injury (n=4) or throughout the ipsilateral hippocampus (n=2) 
and round-shaped microglia/macrophage were sparsely distributed along to the needle 
track in group B. At 72 hours after injury, arborized microglia appeared around the 
injury (n=4) or throughout the ipsilateral hippocampus (n=2) in group A while both of 
the arborized and round-shaped microglia were localized to the margin of the needle 
track in group B. At 7 days after injury, many arborized microglia were observed 
around the injury (n=2) or throughout the ipsilateral hippocampus (n=4) in group A 
while a few round-shaped microglia were localized to the the margin of the needle track 
in group B.  
 
Neu-N: Neuron (Figure 3,4,5) 
There was no statistically significant difference (p=0.7142) in the mean number of 
NeuN-immunopositive neurons in the determined field between group A (339.2) and B 
(328.8) at 24 hours after injury.  At 72 hours after injury, the neuronal loss became 
more evident (p=0.008) in the group B (the mean number of NeuN-immunopositive 
neurons=273.5) compared to that in group A(the mean number of NeuN-immunopositive 
neurons=350.0). However, at 7 days after injury, no statistically significant difference 
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was again revealed (p=0.0785) in the mean number of the NeuN-immunopositive 
neurons in both of the groups (A=238.2, B=267.3) 
 
GFAP: reactive astrocyte (Figure 6)At 24 hours after injury, weakly reactive 
astrocytes were observed around the injury in both of the groups and there was no 
obvious difference in their anatomical distribution. At 72 hours after injury, however, 
weakly (n=2) or moderately (n=4) reactive astrocytes in the dentate gyrus around the 
injury and weakly reactive astrocytes throughout the hippocampus were observed in 
group A while intensely reactive astrocytes in the dentate gyrus around the injury, 
surrounded by the moderately reactive astrocytes (n=6), were observed in group B. At 7 
days after injury, intensely (n=2) or moderately (n=4) reactive astrocytes in the dentate 
gyrus around the injury, surrounded by the weakly reactive astrocytes, were observed in 
group A while intensely (n=6) reactive astrocytes forming gliosis were observed in the 
dentate gyrus around the injury and along to the injury. 
DiscussionIn this study we have shown that the microglial ablation in the acute 
stage of penetrating brain injury at the dentate gyrus of dorsal hippocampus brought 
some remarkable influences to the neurons, astrocytes, and microglia themselves in the 
following time course. 
First, the microglial ablation temporally decelerated the neuronal loss in the acute 
stage, which offset according to the appearance of activated microglia in the subchronic 
stage. At 72 hours post injury, there was a spatial coincidence between the actualization 
of the neuronal loss and the appearance of round-shaped microglia in group B 
(Mac1-SAP(-)).  On the other hand, there was no significant difference in the number 
of surviving neurons in group A (Mac1-SAP(+)) at 24 and 72 hours post injury : in 
group A almost no activated microglia was observed at 24 hours post injury while not 
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round-shaped but arborized microglia appeared at 72 hours post injury. From these 
findings, it is strongly speculated that round-shaped microglia act on the neurons 
suffering injury as attackers probably through phagocytic function2). This speculation 
can be further reinforced by another finding that the same phenomena, as observed in 
group B at 24 and 72 hours post-injury, occurred in group A at 72 and 7 days post-injury 
according to the delayed appearance of round- shaped microglia. 
Second, the progress of astrocytic response was inhibited by the microglial ablation, 
and the inhibition prolonged until 7 days after injury. These findings suggest that 
activated microglia might release some substances4)5) or cause some electrophysiologic 
changes7) to trigger and accerelate hypertrophy and proliferation of astrocytes in the 
acute stage of penetrative brain injury. Furthermore, it is possible that activated 
microglia bring the influence indirectly to the survival/death of the neurons suffering 
injury through the modification of the astrocyte-neuron interaction8). 
Third, the absence of microglia itself proved to be transient. That is, it means that the 
results in this study reflect the environmental changes caused by the transient absence of 
microglia in the acute stage of penetrative brain injury. Such transiency of the 
microglial ablation might be partly due to effectiveness of Mac1-SAP as a microglial 
immunotoxin, and partly due to the migratory character of microglia9) existing the 
surroundings of ablation site.  
0n the bases of the speculations described as above, it can be hypothesized that the 
permanent microglial ablation immediately after penetrative brain injury might inhibit 
constantly the following neuronal loss.  Further experimental trials should be 
performed to verify the validity of this hypothesis and to apply this strategy to the 
clinical cases.the insufficient  
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ConclusionsThe microglial ablation in the acute stage of penetrative brain injury 
at the dentate gyrus of the mouse hippocampus ameliorated the neuronal loss 
following traumatic brain injury and inhibited the hypertrophy and proliferation of 
astrocytes. 
2. Activated microglia in the acute stage of penetrative brain injury are considered to 
mainly act on the neurons suffering injury as attackers through phagocytic function 
and modification of astrocyte-neuron interaction. 
－12－ 
References 
1) Kreutzberg, G.W. Microglia: a sensorfor the pathological events in the CNS. TINS. 1996; 
19, 312-318. 
2) Brierley, J.B., and Brown, A.W. The origin of lipid phagocytes in the central nervous 
system. Ⅰ. The intrinsic microglia. J Comp.Neurol. 1982; 211, 18-25. 
3) Streit, W.J., Graeber, M.B., and Kreutzberg, G.W. Functional plasticity of microglia : a 
review. Glia. 1988; 1, 301-307. 
4) Woodroofe, M.N., Sarna, G.S., Wadhwa, M., Hyass, G.M., Loughlin, A.J., Tinker, A., and 
Cuzner, N.L. Detection of interleukin-1 and interleukin-6 in adult rat brain, following 
mechanical injury, by in vivo microdyalisis : evidence of a role for microglia in cytokine 
production. J. Neuroimmunol. 1991; 33, 227-236. 
5) Chao, C.C., Hu, S., Molitor, W., Shasken, E.G., and Peterson, P.K. Activated microglia 
mediate neuronal cell injury via a nitric oxide mechanism. The Journal of Immunology. 
1992; 149, 2736-2741. 
6) Anti-Mac-1-SAPORIN TARGETED IMMUNOTOXIN in Chemikon 1999 
Immunological Reagents Catalog, p8, ed.by CHEMIKON International Inc. 
7) Kettermann, H., Banati, R., and Walz, W. Electrophysiological behabior of microglia. Glia. 
1993; 7, 93-101. 
8) Martin, D.L. The role of glia in the inactivation of neurotransmitters, in Kettenmann, H., 
and Ransom, B.R.(ed). NEUROGLIA. Oxford University Press, pp732-745. 
9) Happner, F.L., Skutella, T., Hailer, N.P., Haas, D., and Nitsch, R. Activated microglial 
cells migrate towards site of excitotoxic neuronal injury inside organotypic hippocampal 
slice cultures. Eur J Neurosci. 1998; 10, 3284-3290. 
 
 
－13－ 
Microglia
Neuron
Astrocyte
Primary Ab Secondary Ab Method Chromogen
rat anti-mouse 
F4/80  (1:50)
biotinylated rabbit 
anti-rat IgG (1:200)
ABC
mouse anti-
NeuN (1:100)
biotinylated anti-
mouse IgG (1:250)
ABC
Nickel-DAB
DAB
rabbit anti-human 
GFAP (1:50)
HRP-conjugated goat 
anti-rabbit IgG (1:100)
Indirect AEC
Table 1. 　Antibodies and immunohistochemical methods
Figure 1． Schematic summary of experimental protocol
C57/BL6 mice
8W, Male, 
BW20-25g
Group A (total n=18)
Group B (total n=18)
Penetrative injury by 23G 
microsyringe at the dentate 
gyrus of lt dorsal hippocampus
Simultaneous administration 
of 1μl solution*
* Group A : 100ng of Mac1-SAP in PBS
* Group B : PBS only
24h
72h
7d
Transcardial perfusion, brain 
removal, paraffinized section
(n=6 in each time point/group)
Immunohistochemistry
F4/80 :microglia
NeuN : neuron
GFAP : astrocyte
Quantification of 
neuronal loss and 
statistical analysis
Figure 2.   F4/80 : Activated microglia
Mac1-
SAP(-)
Mac1-
SAP(+)
500μm
24hrs 72hrs 7days
ROI :400×300μm
Figure 3. Area of interest for Neu-N positive 
cell count
Figure 4. Neu-N : Neuron
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Figure 5.  Number of Neu-N positive neurons
Figure 6.   GFAP : reactive astrocyte
Mac1-
SAP(-)
Mac1-
SAP(+)
500μm
24hrs 72hrs 7days
